High-grade glioma, an aggressive form of pediatric and adult brain cancer, is challenging to treat given the tumor location, ...

For years, scientists studying brain aging have focused on proteins and DNA. But what if a crucial piece of the puzzlehas ...

Research shows how specific natural nootropics can enhance memory, focus, and cognitive processing while potentially offering ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Despite past failures, Denali's extensive pipeline and solid financial runway make it a compelling buy at current low stock ...

A new research study led by Jonathan D. Santoro, MD, Director of the Neuroimmunology Program at Children’s Hospital Los ...

High-grade glioma, a difficult-to-treat and aggressive form of pediatric and adult brain cancer, responded to FDA-approved avapritinib. | Drug Discovery And Development ...

March is Traumatic Brain Injury Awareness Month, a condition that has led to permanent disability in more than 5 million individuals in the United States. Healio spoke with Gregory Hawryluk, MD, PhD, ...

A protein called HER3, which is present on the blood–brain barrier, helps the tumour-invading protein cross from the ...

In a live event, Ganesh V. Raj, MD, PhD, discussed the drug-drug interactions and outcomes by disease volumes across ARPI trials in mHSPC.

The blood-brain barrier is a network of blood vessels and tissues that acts as a protective shield, preventing harmful substances in the blood from reaching the brain. In Alzheimer’s disease, this ...